Back to top

Chemed Corp. (CHE) Surges: Why It Still Has Room to Run?
February 26, 2014

Read MoreHide Full Article
One company that should be on your radar is Chemed Corp. (CHE - Free Report) . The stock of this healthcare company has seen its Zacks Rank surge over the past four weeks, moving from Hold territory to its current position as a Strong Buy.
A key reason for this move has been the positive trend in the earnings estimate revisions picture. For CHE’S full year estimate, we have seen 1 estimate go higher in the past 30 days, compared to no downward revision. This trend has helped the consensus estimate to trend higher, going from $4.84 a share a month ago to its current level at $5.22.
This positive shift in estimates has made some investors take notice and buy the stock. In fact, CHE has seen some pretty solid trading lately, as the company has moved higher by 11.0% in the past month.
If Chemed Corp. can keep up this great momentum on the earnings estimate front and continue to impress analysts, we could see more gains ahead for this company, suggesting that you might want to put CHE on your watch list for the future.
Other top-ranked stocks worth considering in this space include Almost Family Inc. (AFAM - Free Report) , LCA-Vision Inc. , with a Zacks Rank #1 (Strong Buy) and China Cord Blood Corporation with a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Chemed Corp. (CHE) - free report >>

Almost Family Inc (AFAM) - free report >>

More from Zacks Tale of the Tape

You May Like